MTP Stock Price, News & Analysis
Company Description
MTP (NASDAQ: MTP) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.0M.
MTP stock has declined 66.8% over the past year.
This page provides a comprehensive overview of MTP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
MTP (MTP) stock. Over the past 12 months, the stock has lost 66.8%. At a market capitalization of $2.0M, MTP is classified as a micro-cap stock with approximately 6.9M shares outstanding.
Latest News
MTP has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include private placement, clinical trial. View all MTP news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MTP Company Profile & Sector Positioning
MTP (MTP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing MTP often look at related companies in the same sector, including CDT Equity (CDT), Purple Biotech Ltd (PPBT), Windtree Therapeutics Inc (WINT), Psyence Biomedical Ltd. (PBM), and Scinai Immunotherapeutics Ltd. (SCNI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MTP's relative position within its industry.